Reprint

Creatine Supplementation for Health and Clinical Diseases

Edited by
March 2022
562 pages
  • ISBN978-3-0365-2155-8 (Hardback)
  • ISBN978-3-0365-2156-5 (PDF)

This book is a reprint of the Special Issue Creatine Supplementation for Health and Clinical Diseases that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Creatine plays a critical role in cellular metabolism, primarily by binding with phosphate to form phosphocreatine (PCr) as well as shuttling high-energy phosphate compounds in and out of the mitochondria for metabolism. Increasing the dietary availability of creatine increases the tissue and cellular availability of PCr, and thereby enhances the ability to maintain high-energy states during intense exercise. For this reason, creatine monohydrate has been extensively studied as an ergogenic aid for exercise, training, and sport. Limitations in the ability to synthesize creatine and transport and/or store dietary creatine can impair metabolism and is a contributor to several disease states.  Additionally, creatine provides an important source of energy during metabolically stressed states, particularly when oxygen availability is limited. Thus, researchers have assessed the role of creatine supplementation on health throughout the lifespan, as well as whether creatine availability may improve disease management and/or therapeutic outcomes. This book provides a comprehensive overview of scientific and medical evidence related to creatine's role in metabolism, health throughout the lifespan, and our current understanding of how creatine can promote brain, heart, vascular and immune health; reduce the severity of musculoskeletal and brain injury; and may provide therapeutic benefits in glucose management and diabetes, cancer therapy, inflammatory bowel disease, and post-viral fatigue.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
ergogenic aids; cellular metabolism; phosphagens; sarcopenia; cognition; diabetes; creatine synthesis deficiencies; concussion; traumatic brain injury; spinal cord injury; muscle atrophy; rehabilitation; pregnancy; immunity; anti-inflammatory; antioxidant; anticancer; creatine; nutritional supplements; fertility; pregnancy; newborn; development; brain injury; post-viral fatigue syndrome; chronic fatigue syndrome; creatine; GAA; creatine kinase; dietary supplements; exercise; skeletal muscle; glycemic control; type 2 diabetes mellitus; phosphorylcreatine; dietary supplement; cognition; brain injury; concussion; ergogenic aid; dietary supplement; youth; athletes; sarcopenia; osteoporosis; osteosarcopenia; frailty; cachexia; innate immunity; adaptive immunity; nutritional supplements; inflammation; macrophage polarization; cytotoxic T cells; toll-like receptors; creatine; vascular pathology; cardiovascular disease; oxidative stress; vascular health; female; dietary supplement; menstrual cycle; hormones; exercise performance; menopause; pregnancy; mood; cognition; creatine; children; height; BMI-for-age; stature-for-age; growth; phosphocreatine; creatine transporter; supplementation; treatment; heart; heart failure; ischemia; myocardial infarction; anthracycline; cardiac toxicity; creatine kinase; energy metabolism; cell survival; bioinformatics; systems biology; cellular allostasis; dynamic biosensor; pleiotropic effects of creatine (Cr) supplementation; inflammatory bowel diseases (IBD); ulcerative colitis; Crohn’s disease; creatine kinase (CK); phosphocreatine (PCr); creatine transporter (CrT); intestinal epithelial cell protection; intestinal tissue protection; creatine perfusion; organ transplantation; Adenosine mono-phosphate (AMP); activated protein kinase (AMPK); liver kinase B1 (LKB1); mitochondrial permeability transition pore (mPTP); reactive oxygen species (ROS); glucose transporter (GLUT); creatine; T cell antitumor immunity; metabolic regulator; cancer immunotherapy; supplements; muscle damage; recovery; immobilization; atrophy; muscular dystrophy; amyotrophic lateral sclerosis; Parkinson’s Disease; cardiopulmonary disease; mitochondrial cytopathy; supplements; hypertrophy; sarcopenia; supplementation; ergogenic aid; athletic performance; weightlifting; resistance exercise; training; muscular power; recovery; muscular adaptation; muscle damage; phosphocreatine; muscle fatigue; adipose tissue; muscle strength; dietary supplements; physiological adaptation; adipose tissue; creatine; mitochondria; thermogenesis; creatine kinase; systems biology; bioinformatics; MAP kinase signaling system; sodium-chloride-dependent neurotransmitter symporters; signal transduction; creatine; intradialytic creatine supplementation; hemodialysis; muscle; protein energy wasting; clinical trial; muscle weakness; chronic fatigue; cognitive impairment; depression; anemia; dietary supplements; ergogenic aid; hypertrophy; resistance training; sports nutrition; strength; supplementation; toxicity; methylation; hyperhomocysteinemia; creatine; neuromodulation; MCDA; mitochondriopathia; cardiac infarction; chronic fatigue syndrome; long COVID; ischemia; hypoxia; stroke; neurodegenerative diseases; oxidative stress; noncommunicable disease; adenosine 5′-monopnophosphate-activated protein kinase; anthracyclines; creatine supplementation; cardiac signaling; cardiotoxicity; doxorubicin; soy; vegetarian/vegan diet; creatine; amino acids; dietary supplement; dietary ingredients; ergogenic aids; exercise; performance